Eledon Pharmaceuticals, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-06. The offering totals $22.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Showing 25 of 40 people.
| Name | Role | Location |
|---|---|---|
| Reinhard Ambros | Director | Cambridge, MA |
| David Kessler | Director | TROY, MI |
| Campbell Murray | Director | NOVATO, CA |
| Scott Chappel | Executive Officer | Cambridge, MA |
| John McBride | Director | Toronto, A6 |
| June Lee | Director | Berkeley, CA |
| Bryan Smith | Executive Officer | New York, NY |
| Erez Chimovits | Director | NESS ZIONA, L3 |
| CATHERINE TURKEL | Executive Officer | Kelowna, A1 |
| Keith A Katkin | Director | San Diego, CA |
| Steven Perrin | Director | Irvine, CA |
| Steven Perrin | Executive Officer | Irvine, CA |
| David-Alexandre Gros | Director | Irvine, CA |
| David-Alexandre Gros | Executive Officer | Irvine, CA |
| Allan Kirk | Director | Irvine, CA |
| James Robinson | Director | Morrisville, NC |
| Keith Katkin | Director | Irvine, CA |
| Jan Hillson | Director | Irvine, CA |
| Paul Little | Executive Officer | Pine Ridge, SD |
| Walter Ogier | Director | Irvine, CA |
| Reinhard J Ambros | Director | Waltham, MA |
| Cheryl Cohen | Director | San Diego, CA |
| Gary Lyons | Director | Irvine, CA |
| Gregory Flesher | Director | San Diego, CA |
| Gregory Flesher | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-05-23 | D | — | $50.0M |
| 2023-05-22 | D | — | $35.0M |
| 2020-09-25 | D | $108.1M | $108.1M |
| 2020-01-27 | D | $5.8M | $862K |
| 2019-05-10 | D | $28.5M | $862K |
| 2013-05-15 | D | $35.5M | $20.0M |
| 2011-09-20 | D | $23.0M | $1.9M |